Ubs Oconnor LLC Rhythm Pharmaceuticals, Inc. Transaction History

Ubs Oconnor LLC

  • $1.72 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$15.81 - $27.8 $474,300 - $834,000
30,000 New
30,000 $687,000
Q1 2023

May 15, 2023
BUY
$16.88 - $34.24 $946,124 - $1.92 Million
56,050 New
56,050 $999,000
Q3 2022

Nov 14, 2022
BUY
$4.3 - $30.85 $311,212 - $2.23 Million
72,375 New
72,375 $1.77 Billion

Others Institutions Holding RYTM

# of Institutions
178
Shares Held
69.1M
Call Options Held
467K
Put Options Held
224K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.86B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email